Alzamend Neuro Inc.

NASDAQ: ALZN · Real-Time Price · USD
2.38
-0.05 (-2.06%)
At close: Aug 15, 2025, 3:59 PM
2.41
1.26%
After-hours: Aug 15, 2025, 07:41 PM EDT

Alzamend Neuro Income Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Apr 30, 2025 Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Jul 31, 2023 Apr 30, 2023 Jan 31, 2023 Oct 31, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021 Jan 31, 2021 Oct 31, 2020 Jul 31, 2020
Revenue
n/a 76.11K 76.11K 76.11K 76.11K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
50.74K 50.74K 50.74K 50.74K 50.74K 43.38K 36.02K 28.65K 23.07K 17.74K 12.42K 7.1K n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
-50.74K -50.74K -50.74K -50.74K -50.74K -43.38K -30.69K -23.33K -17.74K -12.42K -12.42K -7.1K n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-4.5M -4.21M -5.83M -7.37M -9.94M -12.39M -15.16M -15.36M -14.87M -15.44M -12.57M -13.05M -12.32M -9.67M -8.23M -5.94M -4.95M -4.99M -5.15M -4.8M
Interest Income
n/a n/a n/a n/a n/a 0.52 0.52 4.11 4.11 3.59 3.59 n/a n/a n/a n/a n/a 1.71K 4.2K 6.74K 11.19K
Pretax Income
-4.51M -4.23M -5.85M -7.39M -9.95M -12.4M -15.17M -15.37M -14.88M -15.44M -12.59M -13.08M -12.36M -9.75M -8.3M -6.05M -5.05M -5.05M -5.2M -4.79M
Net Income
-4.51M -4.23M -5.85M -7.39M -9.95M -12.4M -15.17M -15.37M -14.88M -15.45M -12.59M -13.08M -12.36M -9.75M -8.3M -6.05M -5.05M -5.05M -5.2M -4.79M
Selling & General & Admin
3.08M 3.06M 3.21M 3.07M 3.47M 4.46M 6.26M 6.93M 7.42M 7.98M 7.13M 7.39M 7.12M 5.83M 5.03M 4.02M 3.64M 3.73M 3.7M 3.62M
Research & Development
1.41M 1.15M 2.61M 4.3M 6.46M 7.92M 8.9M 8.44M 7.45M 7.46M 5.44M 5.66M 5.2M 3.83M 3.19M 1.92M 1.31M 1.26M 1.45M 1.18M
Other Expenses
-503 -503 -88 0.00 0.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
4.5M 4.19M 5.8M 7.35M 9.91M 12.38M 15.16M 15.36M 14.87M 15.44M 12.57M 13.05M 12.32M 9.67M 8.23M 5.94M 4.95M 4.99M 5.15M 4.8M
Interest Expense
18.03K 18.98K 19.45K 20.27K 10.1K 9.15K 8.73K 8K 7.7K 7.78K 22.02K 34.43K 46.52K 82.78K 132.12K 172.28K 158.8K 121.94K 56.3K 151.00
Selling & Marketing Expenses
307.3K 304K 291.31K -12.69K 234.65K 481.98K 742K 989.34K 742K 494.67K 247.33K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
4.5M 4.21M 5.83M 7.37M 9.94M 12.39M 15.16M 15.36M 14.87M 15.44M 12.57M 13.05M 12.32M 9.67M 8.23M 5.94M 4.95M 4.99M 5.15M 4.8M
Income Tax Expense
n/a -2 -7 -7 -30.6K -37.78K -37.77K -34.19K -2.06K 1.72K 1.72K -1.87K -3.4K n/a n/a n/a n/a n/a 2.54K 6.99K
Shares Outstanding (Basic)
778.73K 5.52M 3.53M 777.82K 3.44M 705.43K 3.28M 3.28M 3.23M 3.27M 3.25M 3.25M 2.93M 3.13M 3.12M 2.77M 2.46M 2.4M 2.4M 2.4M
Shares Outstanding (Diluted)
778.73K 5.52M 3.53M 777.82K 3.44M 705.43K 3.28M 3.28M 3.23M 3.28M 3.25M 3.25M 2.93M 3.14M 3.12M 2.77M 2.46M 2.41M 2.41M 2.41M
EPS (Basic)
-4.06 -3.08 -6.66 -10.69 -14.82 -18.7 -23.23 -23.6 -22.72 -24.2 -20.4 -21.38 -17.72 -13.67 -11.04 -7.52 -8.88 -8.95 -9.75 -9.48
EPS (Diluted)
-4.06 -3.08 -6.66 -10.69 -14.82 -18.7 -23.23 -23.6 -22.72 -24.2 -20.4 -21.6 -17.94 -13.89 -11.26 -7.52 -8.88 -8.95 -9.75 -9.48
EBITDA
-4.45M -4.16M -5.78M -7.32M -9.89M -12.35M -15.12M -15.33M -14.85M -15.42M -12.56M -13.04M -12.32M -9.67M -8.16M -5.88M -4.89M -4.94M -3.88M -2.58M
EBIT
-4.5M -4.21M -5.83M -7.37M -9.94M -12.39M -15.16M -15.36M -14.87M -15.43M -12.57M -13.05M -12.32M -9.67M -8.16M -5.88M -4.89M -4.94M -5.16M -4.81M
Depreciation & Amortization
50.74K 50.74K 50.74K 50.74K 50.74K 43.38K 36.02K 28.65K 23.07K 18.63K 1.14M 2.42M 4.72M 5.94M 5.92M 5.94M 4.95M 4.99M 5.15M 4.8M